Lataa...
Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Several mood-stabilizing atypical antipsychotics and antidepressants weakly block serotonin (5-HT) receptor type-7 (5-HT7R); however, the contributions of 5-HT7R antagonism to clinical efficacy and pathophysiology are yet to be clarified. A novel mood-stabilizing antipsychotic agent, lurasidone exhi...
Tallennettuna:
| Julkaisussa: | Front Psychiatry |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930824/ https://ncbi.nlm.nih.gov/pubmed/33679481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2021.623684 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|